Darrell H. Tan, Ph.D.
Affiliations: | 2012 | Health Policy, Management and Evaluation | University of Toronto, Toronto, ON, Canada |
Area:
Medicine and Surgery, Epidemiology, Virology BiologyGoogle:
"Darrell Tan"Parents
Sign in to add mentorSharon Walmsley | grad student | 2012 | University of Toronto | |
(Clinical Implications of HIV-1, HSV-2 Co-Infection and Opportunities for Intervention.) |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Monti EB, Penichet D, Rudd M, et al. (2025) Hepatitis B prevention interventions during HIV post-exposure prophylaxis visits: A retrospective chart review. International Journal of Std & Aids. 9564624251325312 |
Tharao W, Nyoni T, Daftary A, et al. (2025) Post-arrival HIV acquisition patterns: Insights from African, Caribbean, and Black immigrant communities in Canada. Canadian Journal of Public Health = Revue Canadienne De Sante Publique |
Halani S, Tan D, Andany N. (2024) Long-acting injectable antiretroviral therapy for HIV-1 infection in adults. Cmaj : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne. 196: E341-E342 |
Clifford Rashotte M, Yoong D, Naccarato M, et al. (2023) Appropriate usage of post-exposure prophylaxis-in-pocket for HIV prevention by individuals with low-frequency exposures. International Journal of Std & Aids. 9564624231215151 |
McClymont E, Tan DH, Bondy S, et al. (2023) HSV-2 infection and HPV incidence, persistence, and precancerous lesions in a cohort of HPV-vaccinated women living with HIV. International Journal of Std & Aids. 9564624231154298 |
Thornhill JP, Barkati S, Walmsley S, et al. (2022) Monkeypox Virus Infection in Humans across 16 Countries - April-June 2022. The New England Journal of Medicine |
Wobeser WL, McBane JE, Balfour L, et al. (2022) A randomized control trial of high-dose micronutrient-antioxidant supplementation in healthy persons with untreated HIV infection. Plos One. 17: e0270590 |
Christensen BL, Tan DH. (2022) An up-to-date evaluation of dolutegravir/abacavir/lamivudine for the treatment of HIV. Expert Opinion On Pharmacotherapy. 23: 439-446 |
Costiniuk CT, Singer J, Langlois MA, et al. (2021) CTN 328: immunogenicity outcomes in people living with HIV in Canada following vaccination for COVID-19 (HIV-COV): protocol for an observational cohort study. Bmj Open. 11: e054208 |
Suri S, Yoong D, Short D, et al. (2021) Feasibility of implementing a same-day electronic screening tool for clinical assessment to measure patient-reported outcomes for eliciting actionable information on adherence to HIV medication and related factors in a busy Canadian urban HIV clinic. International Journal of Std & Aids. 9564624211032796 |